Innovator IBD 50 ETF (NYSEARCA:FFTY) Sees Large Decline in Short Interest

Innovator IBD 50 ETF (NYSEARCA:FFTY) saw a significant decline in short interest in the month of September. As of September 30th, there was short interest totaling 8,533 shares, a decline of 67.4% from the September 15th total of 26,201 shares. Based on an average trading volume of 8,524 shares, the short-interest ratio is presently 1.0 days. Approximately 0.4% of the shares of the company are sold short.

Innovator IBD 50 ETF Price Performance

Innovator IBD 50 ETF stock traded down $1.51 during mid-day trading on Wednesday, reaching $33.64. 20,372 shares of the stock traded hands, compared to its average volume of 51,112. The stock has a market capitalization of $65.60 million, a PE ratio of 30.34 and a beta of 1.48. Innovator IBD 50 ETF has a 12-month low of $31.61 and a 12-month high of $44.08. The business’s 50-day moving average is $36.02 and its 200-day moving average is $37.94.

Institutional Investors Weigh In On Innovator IBD 50 ETF

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Kraematon Investment Advisors Inc. bought a new position in shares of Innovator IBD 50 ETF during the 2nd quarter valued at about $1,021,000. Guardian Wealth Advisors LLC NC bought a new stake in shares of Innovator IBD 50 ETF in the second quarter worth about $507,000. Royal Bank of Canada increased its holdings in shares of Innovator IBD 50 ETF by 3,222.5% in the first quarter. Royal Bank of Canada now owns 18,274 shares of the company’s stock worth $611,000 after purchasing an additional 17,724 shares during the last quarter. Concurrent Investment Advisors LLC increased its holdings in shares of Innovator IBD 50 ETF by 11.1% in the second quarter. Concurrent Investment Advisors LLC now owns 63,128 shares of the company’s stock worth $3,349,000 after purchasing an additional 6,321 shares during the last quarter. Finally, Trail Ridge Investment Advisors LLC purchased a new stake in shares of Innovator IBD 50 ETF in the second quarter worth about $210,000.

Innovator IBD 50 ETF Company Profile

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.